Burden of Clostridium difficile infection in the United States.

Fernanda C. Lessa, M.D., M.P.H., Yi Mu, Ph.D., Wendy M. Bamberg, M.D., Zintars G. Beldavs, M.S., Ghinwa K. Dumyati, M.D., John R. Dunn, D.V.M., Ph.D., Monica M. Farley, M.D., Stacy M. Holzbauer, D.V.M., M.P.H., James I. Meek, M.P.H., Erin C. Phipps, D.V.M., M.P.H., Lucy E. Wilson, M.D., Lisa G. Winston, M.D., Jessica A. Cohen, M.P.H., Brandi M. Limbago, Ph.D., Scott K. Fridkin, M.D., Dale N. Gerding, M.D., and L. Clifford McDonald, M.D.

[1]  J. Bartlett,et al.  Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. , 1981, Gastroenterology.

[2]  R. Möllby,et al.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. , 1985, The Journal of infectious diseases.

[3]  Roderick J. A. Little,et al.  Multiple Imputation for the Fatal Accident Reporting System , 1991 .

[4]  R. Platt,et al.  Epidemiology of community-acquired Clostridium difficile-associated diarrhea. , 1994, The Journal of infectious diseases.

[5]  Sharon L. Lohr,et al.  Sampling: Design and Analysis , 1999 .

[6]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[7]  T. Åkerlund,et al.  Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County , 2004, Journal of Clinical Microbiology.

[8]  D. Musher,et al.  Treatment of Clostridium difficile-associated disease: old therapies and new strategies. , 2005, The Lancet. Infectious diseases.

[9]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[10]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[11]  A. Robicsek,et al.  Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Woods,et al.  Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphis , 2007, Journal of Clinical Microbiology.

[13]  S. Persson,et al.  New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  M. Wilcox,et al.  A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.

[15]  R. Campbell,et al.  Clostridium difficile Infection in Ohio Hospitals and Nursing Homes During 2006 , 2009, Infection Control & Hospital Epidemiology.

[16]  Mark A. Miller,et al.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. P. Bauer,et al.  The Changing Epidemiology of Clostridium difficile Infections , 2010, Clinical Microbiology Reviews.

[18]  C. Burnham,et al.  Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile Infections , 2011, Journal of Clinical Microbiology.

[19]  D. Anderson,et al.  Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.

[20]  C. Donskey,et al.  Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Anil K. Jain,et al.  Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. Nathwani,et al.  Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106. , 2011, The Journal of hospital infection.

[23]  N. Khardori.  Clostridium difficile infection in Europe: a hospital-based survey , 2011 .

[24]  J. Weese,et al.  Clostridium difficile and methicillin-resistant Staphylococcus aureus shedding by slaughter-age pigs , 2011, BMC veterinary research.

[25]  J. Stockman.  Treatment with Monoclonal Antibodies against Clostridium difficile Toxins , 2011 .

[26]  Guang-xi Li,et al.  Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA) , 2011 .

[27]  C. Mcnulty,et al.  Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. , 2012, The Journal of antimicrobial chemotherapy.

[28]  Margaret A. Olsen,et al.  Burden of Clostridium difficile on the Healthcare System , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Amanda F. Petrik,et al.  Clostridium difficile Infection, Colorado and the Northwestern United States, 2007 , 2012, Emerging infectious diseases.

[30]  M. Cairns,et al.  Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Nauta,et al.  Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009 , 2012, Epidemiology and Infection.

[32]  J. Weese,et al.  Prevalence and molecular characterization of Clostridium difficile isolated from feedlot beef cattle upon arrival and mid-feeding period , 2012, BMC Veterinary Research.

[33]  J. Haagsma,et al.  Disease burden of foodborne pathogens in the Netherlands, 2009. , 2012, International journal of food microbiology.

[34]  G. Dumyati,et al.  Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York , 2012, Infection Control & Hospital Epidemiology.

[35]  A. Curns,et al.  The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  T. Peto,et al.  Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  A. Carmichael,et al.  Mortality in Clostridium difficile infection: a prospective analysis of risk predictors , 2013, European journal of gastroenterology & hepatology.

[38]  K.,et al.  Attributable Burden of Hospital-Onset Clostridium difficile Infection: A Propensity Score Matching Study , 2013, Infection Control & Hospital Epidemiology.

[39]  D. Crook,et al.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection , 2013, Lancet. Infectious Diseases (Print).

[40]  O. Dekkers,et al.  All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  S. Trottier,et al.  Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  D. Gerding,et al.  Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  D. Gerding,et al.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. , 2013, JAMA internal medicine.

[44]  B. Limbago,et al.  Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States , 2013, Journal of Clinical Microbiology.

[45]  D. Harris,et al.  Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[46]  S. Cosgrove,et al.  Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era , 2014, Infection Control & Hospital Epidemiology.

[47]  M. Olsen,et al.  Development and validation of a recurrent Clostridium difficile risk-prediction model. , 2014, Journal of hospital medicine.

[48]  K. Garey,et al.  Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1 , 2014, Infection Control & Hospital Epidemiology.

[49]  J. Meek,et al.  Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations , 2014, Open forum infectious diseases.

[50]  J. Meek,et al.  Clostridium difficile Infection Among Children Across Diverse US Geographic Locations , 2014, Pediatrics.

[51]  D. Gerding,et al.  NAP1 strain type predicts outcomes from Clostridium difficile infection. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  R. Lynfield,et al.  Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.

[53]  Monique L. Anderson,et al.  Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.

[54]  J. Bartlett.  Clostridium difficile Infection. , 2017, Infectious disease clinics of North America.